ProCE Banner Activity

CE / CME

COVID Rounds: Inpatient Management of Patients With Mild or Moderate COVID-19

Video

Learn from experts on best practices for managing mild to moderate COVID-19 in the hospital setting based on guideline recommendations and clinical data. 

Nurses: 0.75 Nursing contact hour

Pharmacists: 0.75 contact hour (0.075 CEUs)

Physicians: maximum of 0.75 AMA PRA Category 1 Credit

Released: December 18, 2024

Expiration: December 17, 2025

Share

Faculty

Victoria (Patient)

Victoria (Patient), PhD, MSW

Patient

Stephen Cantrill

Stephen Cantrill, MD, FACEP

Associate Director and Medical Director (Retired)
Department of Emergency Medicine
Denver Health Medical Center
Associate Professor
Department of Emergency Medicine
University of Colorado Health Sciences Center
Denver, Colorado

Rajesh T. Gandhi

Rajesh T. Gandhi, MD

Massachusetts General Hospital
Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Payal K. Patel

Payal K. Patel, MD, MPH, FIDSA

Systemwide Director of Antimicrobial Stewardship
Associate Professor, Division of Infectious Diseases
Intermountain Health
Salt Lake City, Utah

Provided by

Provided by Clinical Care Options, LLC in partnership with Practicing Clinicians Exchange, ProCE, and the American Academy of Emergency Medicine (AAEM)  

ProCE Banner

Supporters

Supported by an educational grant from Gilead Sciences, Inc.

Gilead Sciences, Inc.

Partners

American Academy of Emergency Medicine (AAEM)

ProCE Banner

Practicing Clinicians Exchange

ProCE Banner

ProCE

ProCE Banner

Target Audience

This activity is intended for multispecialty physicians, nurse practitioners, clinical pharmacists, and nurses involved in the care of hospitalized patients with COVID-19.

Program Learning Goal

The goal of this activity is to improve the knowledge and competence of learners in effort to optimize treatment for patients with COVID.

Learning Objectives

Upon completion of this activity, participants should be able to: 

  • Identify hospitalized patients with COVID-19 who are at risk for severe outcomes to guide therapeutic plans

  • Integrate clinical practice guideline recommendations into inpatient COVID-19 management strategies

Disclosure

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Primary Author

Stephen Cantrill, MD, FACEP

Associate Director and Medical Director (Retired)
Department of Emergency Medicine
Denver Health Medical Center
Associate Professor
Department of Emergency Medicine
University of Colorado Health Sciences Center
Denver, Colorado

Stephen Cantrill, MD, FACEP, has no relevant financial relationships to disclose.

Rajesh T. Gandhi, MD

Massachusetts General Hospital
Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Rajesh T. Gandhi, MD, has no relevant financial relationships to disclose.

Payal K. Patel, MD, MPH, FIDSA

Systemwide Director of Antimicrobial Stewardship
Associate Professor, Division of Infectious Diseases
Intermountain Health
Salt Lake City, Utah

Payal K. Patel, MD, MPH, FIDSA: consultant/advisor/speaker: Cormedix, Roche Diagnostics.

Victoria (Patient), PhD, MSW

Patient

Victoria (patient) has no relevant financial relationships to disclose.

The planners and content peer reviewers from Clinical Care Options, LLC, Practicing Clinicians Exchange, ProCE, and the American Academy of Emergency Medicine (AAEM) do not have any relevant financial relationships to disclose.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 0.75 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from December 18, 2024, through December 17, 2025:

  1. Login or Sign Up for an account by clicking at the top of this page.

  2. Read the target audience, learning objectives, and faculty disclosures.

  3. View and study the content in its entirety.

  4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65 and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.

Format

This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 0.75 contact hours.

Continuing Pharmacy Education

CCO designates this continuing education activity for 0.75 contact hours (0.075 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-0000-24-340-H01-P 

Type of Activity: Application

Upon successfully completing the post-test with a score of 65% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

CME Passport

https://omni-channel-2022-assets-production.s3.amazonaws.com/editorupload/662be69741e7b.png

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.org to create your account.